Labcorp Pre-Paid Expenses 2010-2024 | LH

Labcorp pre-paid expenses from 2010 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
  • Labcorp pre-paid expenses for the quarter ending June 30, 2024 were $0.618B, a 6.35% decline year-over-year.
  • Labcorp pre-paid expenses for 2023 were $0.655B, a 7.36% increase from 2022.
  • Labcorp pre-paid expenses for 2022 were $0.61B, a 27.67% increase from 2021.
  • Labcorp pre-paid expenses for 2021 were $0.478B, a 31.06% increase from 2020.
Labcorp Annual Pre-Paid Expenses
(Millions of US $)
2023 $655
2022 $610
2021 $478
2020 $365
2019 $374
2018 $309
2017 $309
2016 $321
2015 $339
2014 $158
2013 $107
2012 $75
2011 $80
2010 $96
2009 $80
Labcorp Quarterly Pre-Paid Expenses
(Millions of US $)
2024-06-30 $618
2024-03-31 $678
2023-12-31 $655
2023-09-30 $700
2023-06-30 $660
2023-03-31 $770
2022-12-31 $610
2022-09-30 $512
2022-06-30 $482
2022-03-31 $516
2021-12-31 $478
2021-09-30 $518
2021-06-30 $462
2021-03-31 $417
2020-12-31 $365
2020-09-30 $327
2020-06-30 $318
2020-03-31 $353
2019-12-31 $374
2019-09-30 $298
2019-06-30 $299
2019-03-31 $317
2018-12-31 $309
2018-09-30 $293
2018-06-30 $286
2018-03-31 $347
2017-12-31 $309
2017-09-30 $450
2017-06-30 $379
2017-03-31 $343
2016-12-31 $321
2016-09-30 $326
2016-06-30 $297
2016-03-31 $360
2015-12-31 $339
2015-09-30 $378
2015-06-30 $387
2015-03-31 $320
2014-12-31 $158
2014-09-30 $126
2014-06-30 $115
2014-03-31 $125
2013-12-31 $107
2013-09-30 $80
2013-06-30 $75
2013-03-31 $67
2012-12-31 $75
2012-09-30 $78
2012-06-30 $68
2012-03-31 $70
2011-12-31 $80
2011-09-30 $78
2011-06-30 $64
2011-03-31 $72
2010-12-31 $96
2010-09-30 $69
2010-06-30 $69
2010-03-31 $74
2009-12-31 $80
2009-09-30 $96
2009-06-30 $68
2009-03-31 $71
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $19.078B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.939B 18.14
McKesson (MCK) United States $66.345B 18.25
Cardinal Health (CAH) United States $26.957B 14.91
West Pharmaceutical Services (WST) United States $22.428B 43.73
Cooper (COO) United States $22.013B 31.33
Align Technology (ALGN) United States $18.899B 36.51
Henry Schein (HSIC) United States $9.181B 16.81
Merit Medical Systems (MMSI) United States $5.746B 30.37
DENTSPLY SIRONA (XRAY) United States $5.414B 14.52
CONMED (CNMD) United States $2.343B 20.38
Patterson (PDCO) United States $1.936B 10.21
STAAR Surgical (STAA) United States $1.544B 69.76
Lifevantage (LFVN) United States $0.127B 17.48
Pro-Dex (PDEX) United States $0.086B 41.13